KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Equity (2016 - 2025)

Neogenomics' Return on Equity history spans 15 years, with the latest figure at 0.13% for Q4 2025.

  • For Q4 2025, Return on Equity fell 4.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.13%, down 4.0%, while the annual FY2025 figure was 0.12%, 4.0% down from the prior year.
  • Return on Equity reached 0.13% in Q4 2025 per NEO's latest filing, up from 0.13% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.07% in Q2 2021 to a low of 0.16% in Q3 2022.
  • Average Return on Equity over 5 years is 0.08%, with a median of 0.09% recorded in 2023.
  • Peak YoY movement for Return on Equity: rose 8bps in 2021, then dropped -21bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then crashed by -1829bps to 0.14% in 2022, then surged by 35bps to 0.09% in 2023, then rose by 7bps to 0.09% in 2024, then plummeted by -48bps to 0.13% in 2025.
  • Per Business Quant, the three most recent readings for NEO's Return on Equity are 0.13% (Q4 2025), 0.13% (Q3 2025), and 0.12% (Q2 2025).